SI0776197T1 - Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives - Google Patents

Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives

Info

Publication number
SI0776197T1
SI0776197T1 SI9530203T SI9530203T SI0776197T1 SI 0776197 T1 SI0776197 T1 SI 0776197T1 SI 9530203 T SI9530203 T SI 9530203T SI 9530203 T SI9530203 T SI 9530203T SI 0776197 T1 SI0776197 T1 SI 0776197T1
Authority
SI
Slovenia
Prior art keywords
therapeutic system
oestradiol
transdermal therapeutic
hydrophyllic
additives
Prior art date
Application number
SI9530203T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Horstmann
Walter Mller
Hanshermann Franke
Thomas Pontzen
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh
Publication of SI0776197T1 publication Critical patent/SI0776197T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9530203T 1994-08-20 1995-08-12 Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives SI0776197T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4429664A DE4429664C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
EP95929104A EP0776197B1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen
PCT/EP1995/003202 WO1996005815A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (1)

Publication Number Publication Date
SI0776197T1 true SI0776197T1 (en) 1999-04-30

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530203T SI0776197T1 (en) 1994-08-20 1995-08-12 Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives

Country Status (21)

Country Link
EP (1) EP0776197B1 (sv)
JP (1) JPH10504314A (sv)
KR (1) KR100374476B1 (sv)
CN (1) CN1073413C (sv)
AT (1) ATE173163T1 (sv)
AU (1) AU700119B2 (sv)
CA (1) CA2197865C (sv)
CZ (1) CZ50897A3 (sv)
DE (2) DE4429664C2 (sv)
DK (1) DK0776197T3 (sv)
ES (1) ES2126308T3 (sv)
FI (1) FI118721B (sv)
HU (1) HUT77093A (sv)
IL (1) IL114948A (sv)
NO (1) NO970553L (sv)
NZ (1) NZ291449A (sv)
PL (1) PL180943B1 (sv)
SI (1) SI0776197T1 (sv)
SK (1) SK280299B6 (sv)
WO (1) WO1996005815A1 (sv)
ZA (1) ZA956926B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (sv) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (sv) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut

Also Published As

Publication number Publication date
SK280299B6 (sk) 1999-11-08
CA2197865C (en) 2005-10-25
KR970705380A (ko) 1997-10-09
KR100374476B1 (ko) 2003-04-23
MX9701301A (es) 1998-05-31
IL114948A (en) 2000-10-31
WO1996005815A1 (de) 1996-02-29
ES2126308T3 (es) 1999-03-16
IL114948A0 (en) 1995-12-08
CZ50897A3 (en) 1997-06-11
ATE173163T1 (de) 1998-11-15
PL180943B1 (pl) 2001-05-31
AU3258395A (en) 1996-03-14
SK21997A3 (en) 1997-07-09
AU700119B2 (en) 1998-12-24
CN1155836A (zh) 1997-07-30
DE59504233D1 (de) 1998-12-17
DK0776197T3 (da) 1999-07-26
DE4429664C2 (de) 1997-09-11
CN1073413C (zh) 2001-10-24
EP0776197B1 (de) 1998-11-11
FI970702A (sv) 1997-02-19
PL319014A1 (en) 1997-07-21
EP0776197A1 (de) 1997-06-04
HUT77093A (hu) 1998-03-02
DE4429664A1 (de) 1996-02-22
ZA956926B (en) 1996-03-25
NO970553D0 (no) 1997-02-06
NO970553L (no) 1997-02-06
CA2197865A1 (en) 1996-02-29
FI118721B (sv) 2008-02-29
NZ291449A (en) 1998-09-24
FI970702A0 (sv) 1997-02-19
JPH10504314A (ja) 1998-04-28

Similar Documents

Publication Publication Date Title
EP0384266A3 (en) Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
SI0776197T1 (en) Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives
MX9701302A (es) Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.
SI0865274T1 (en) Surface-stabilised pharmaceutical preparation for application on the skin
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives